Vascular Medicine News

PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.

A system for mechanical thrombectomy treating ischemic stroke demonstrated a high level of sensitivity and specificity compared with human evaluation in a recent clinical trial, according to the manufacturer.

BOSTON — Long-term osilodrostat therapy may improve symptoms of comorbid cardiometabolic disorders such as hypertension and diabetes for adults with Cushing’s disease, according to data presented at ENDO 2024.

PHILADELPHIA — Despite there being few options to directly lower lipoprotein(a) as of yet, measurement is none the less important to identify those who would benefit from improved risk factor control, a speaker reported.

Most high and moderate risk factors for preeclampsia have increased from 2010 to 2021 in the U.S., according to a research letter published in JAMA.

PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, highlights the need for greater prevention of myocardial infarction and cardiovascular death in young women.

The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release.

PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference.

Among pediatric patients with homozygous familial hypercholesterolemia and elevated LDL despite optimal lipid-lowering therapy, evinacumab durably reduced LDL and other significant lipid parameters out to 72 weeks, a speaker reported.